Products & Reviews

The BIOFIRE® ME Panel tests for a comprehensive set of 14 pathogens, including bacteria, viruses, and yeast, identifying the underlying cause of central nervous system infections, which in some cases can be life-threatening.

A powerful combination of multiplex PCR technology and syndromic testing to deliver a new standard for reliable, comprehensive diagnostics.

The BIOFIRE® BCID2 Panel tests for 43 targets associated with bloodstream infections, including gram-negative bacteria, gram-positive bacteria, yeast, and 10 antimicrobial resistance genes.

The BIOFIRE® GI Panel tests stool specimens for a comprehensive set of 22 gastrointestinal pathogens, including common targets associated with gastroenteritis.

The BIOFIRE® PN Panel identifies 33 targets from sputum-like (including endotracheal aspirate) and bronchoalveolar lavage (BAL)-like (BAL or mini-BAL) samples.

The BIOFIRE® RP2.1 Panel helps clinicians quickly diagnose respiratory tract infections by detecting pathogens like SARS-CoV-2, influenza, RSV, and many others.

Mass spectrometry microbial identification system

The BIOFIRE® JI Panel tests for a comprehensive grouping of gram-positive and gram-negative bacteria, yeast, and antimicrobial resistance genes most often associated with joint infections.